The Enterprise Value as of November 2024 (TTM) for Axcella Health Inc. (AXLA) is -7493000.00

According to Axcella Health Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -7493000.00. This represents a change of -100.76% compared to the average of 987.77M of the last 4 quarters.

Axcella Health Inc. (AXLA) Historical Enterprise Value (quarterly & annually)

How has AXLA Enterprise Value performed in the past?

The mean historical Enterprise Value of Axcella Health Inc. over the last ten years is 3.24B. The current -7493000.00 Enterprise Value has changed -123.15% with respect to the historical average. Over the past ten years (40 quarters), AXLA's Enterprise Value was at its highest in in the March 2019 quarter at 7.89B. The Enterprise Value was at its lowest in in the March 2018 quarter at 0.

Axcella Health Inc. (AXLA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Axcella Health Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Axcella Health Inc. (AXLA) Average Enterprise Value

How has AXLA Enterprise Value performed in the past?

The current Enterprise Value of Axcella Health Inc. (AXLA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Axcella Health Inc. (AXLA) Enterprise Value vs. Peers

How is AXLA’s Enterprise Value compared to its peers?

Axcella Health Inc.’s Enterprise Value is less than Cyclerion Therapeutics, Inc. (2.56M), greater than Magenta Therapeutics, Inc. (-114170976.00), less than Kezar Life Sciences, Inc. (41.06M), less than ContraFect Corporation (-1135867.00), less than Panbela Therapeutics, Inc. (5.93M), less than CytomX Therapeutics, Inc. (47.40M), less than Aridis Pharmaceuticals, Inc. (1.40M), less than Neoleukin Therapeutics, Inc. (-6333315.00), less than Assembly Biosciences, Inc. (90.29M), less than Instil Bio, Inc. (258.54M), less than Nuvation Bio Inc. (1.02B), less than Akari Therapeutics, Plc (26.33M), less than Salarius Pharmaceuticals, Inc. (-1183141.00), less than Histogen Inc. (-3675930.00), less than RenovoRx, Inc. (13.20M), less than Adial Pharmaceuticals, Inc. (3.15M), less than Better Therapeutics, Inc. (7.71M), less than Pasithea Therapeutics Corp. (-4187996.00),

Build a custom stock screener for Axcella Health Inc. (AXLA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Axcella Health Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Axcella Health Inc. (AXLA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Axcella Health Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.